You haven't searched anything yet.
The Company:
WHAT IF THE SECRET OF HEALTH LIES AT THE CENTER OF DISEASE? At Sonata Therapeutics, we are designing Network Medicines(TM)that reprogram diseased cells to become the coordinators of cure.
Through a combination of our proprietary genetic library, comprehensive biochemical and functional characterization, and the latest advancements in machine learning algorithms, we are generating a deep understanding of how to reshape multicellular networks to guide the development of transformative therapeutics. While initially focused on oncology, our network-based approach is applicable across many intractable diseases.
Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences companies. Since 2000, Flagship has originated and fostered the development of nearly 100 scientific ventures resulting in $20 billion in aggregate value, 500 issued patents, and more than 50 clinical trials for novel therapeutic agents.
The Position
Due to our success, we are currently on the hunt for a creative, collaborative, Scientist I or II to support the development of new Network Medicines(TM). This individual will work across a matrixed organization to advance programs from lead optimization through IND-enabling activities, with the ultimate goal of demonstrating thereapeutic Proof-of-Concept in the clinic.
As a Scientist I or II, you will be a key contributor in exploring novel target mechanisms and developing novel small molecule Network Medicines(TM). You will be an ambitious and collaborative scientist with a strong background in cell & molecular biology. We are searching for enthusiastic, innovative, and highly motivated individuals who are comfortable working in a fast-paced entrepreneurial environment.
Sonata Therapeutics offers the challenge and opportunity to work at an early-stage, big concept biotechnology company. Your efforts will directly impact the expansion of our R&D portfolio, including existing, early-stage research programs as well as first-in-human clinical studies within the next 18 months that will lead to the development of new, life-changing, innovative therapies.
You will be making a significant impact by...
As an excellent candidate, you will possess…
Sonata Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or veteran status.
Full Time
Business Services
$135k-169k (estimate)
10/18/2023
06/11/2024
flagshippioneering.com
CAMBRIDGE, MA
500 - 1,000
2000
VOLKER HERRMANN
$50M - $200M
Business Services
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other insti...tutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
More
Show less